Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered...
Author - David Miller
Industry Outlook 2025: Talent Up for Grabs
Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the impact of the...
Getting JUV-161 to Phase I in 2025
Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, discusses getting JUV-161 into...
How AI is Shaking Up Pharma Marketing
Ted Sweetser discusses how the technology is expanding the amount of content that can be created.
Using AI to Predict Launch Success
How to maximize market-entry performance for new pharma products in an increasingly competitive...
Study: GLP-1, SGLT2s Linked to Reduced Alzheimer Disease Risk in...
A new study found that patients with type 2 diabetes treated with GLP-1 receptor agonists and...
Novartis to Expand US-Based R&D and Manufacturing
The company has plans to invest $23 billion during the next five years to expand manufacturing and...
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal...
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices...
3D Screen Printing: Enabling A New Generation of Complex...
3D screen printing provides innovative drug development capabilities that are difficult or...
BDD Opens GMP Manufacturing Facility in Scotland
Development of the state-of-the-art facility was made possible by a £2 million (US$2.6 million)...